Quantcast
Last updated on April 19, 2014 at 1:20 EDT

Latest Solta Medical Inc. Stories

2011-11-30 15:05:00

HAYWARD, Calif., Nov. 30, 2011 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced that it will present at the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorder Medical Device Conference at the St. Regis Hotel in San Francisco on Tuesday, December 6, 2011 at 9:40 am Pacific Time. Stephen J. Fanning, Chairman, President and Chief Executive Officer, will review the company's business strategy and...

2011-11-08 15:05:00

HAYWARD, Calif., Nov. 8, 2011 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced that Stephen J. Fanning, Chairman, President & CEO, will be presenting at the following upcoming investor conferences: Lazard Capital Markets 8th Annual Healthcare ConferenceDate: Tuesday, November 15, 2011Time: 2:30 p.m. ETLocation: New York, NY Southwest IDEAS ConferenceDate: Thursday, November 17, 2011Time: 2:20 p.m. CTLocation: Dallas,...

2011-11-03 15:05:00

HAYWARD, Calif., Nov. 3, 2011 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced that Health Canada has granted clearance of the second generation LipoSonix® system for non-invasive waist circumference reduction. The LipoSonix system uses advanced high-intensity focused ultrasound (HIFU) technology as a noninvasive, nonsurgical approach to permanently destroy targeted fat just beneath the skin in the...

2011-11-01 15:05:00

HAYWARD, Calif. and SCOTTSDALE, Ariz., Nov. 1, 2011 /PRNewswire/ -- Solta Medical, Inc. (Solta) (NASDAQ:SLTM) and Medicis Pharmaceutical Corporation (Medicis) (NYSE:MRX) today announced that the two companies have closed their previously announced Stock Purchase Agreement for Solta to acquire all of the outstanding shares of Medicis Technologies Corporation (formerly LipoSonix, Inc.), a subsidiary of Medicis. "The addition of LIPOSONIX® adds another innovative...

2011-11-01 15:02:00

HAYWARD, Calif., Nov. 1, 2011 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today reported product revenue grew year-over-year by 14% for the third quarter ended September 30, 2011. Sales of new systems and upgrades rose year-over-year by $1.8 million, or 19%, to $11.1 million. Revenue from treatment tips and other consumables of $14.9 million grew $1.4 million, or 11%, as compared to the third quarter of 2010, and accounted for...

2011-10-26 15:05:00

HAYWARD, Calif., Oct. 26, 2011 /PRNewswire/ -- Solta Medical, Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics market, today announced that it has signed an amendment with Silicon Valley Bank, a member company of SVB Financial Group, under which the company's credit facility has been expanded from $18 million to $28 million. The Amendment provides for the additional $10.0 million under the secured term loan. "We are very pleased to be working with Silicon Valley Bank. Our...

2011-10-24 15:07:00

HAYWARD, Calif., Oct. 24, 2011 /PRNewswire/ -- Solta Medical, Inc. (Solta) (Nasdaq: SLTM), a global leader in the medical aesthetics market, today announced that Medicis Technologies Corporation (formerly LipoSonix, Inc.), a subsidiary of Medicis Pharmaceutical Corporation (Medicis) has received U.S. Food and Drug Administration (FDA) clearance of the second generation LipoSonix system specifically indicated for non-invasive waist circumference reduction. The LipoSonix system delivers high...

2011-10-18 05:30:00

HAYWARD, Calif., Oct. 18, 2011 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced that it will release its financial results for the third quarter ended September 30, 2011, after market close on Tuesday, November 1, 2011. The Company will also host a conference call and webcast on Tuesday, November 1, 2011, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss the financial results and current corporate developments,...

2011-08-31 07:30:00

HAYWARD, Calif., Aug. 31, 2011 /PRNewswire/ -- Solta Medical, Inc. (Nasdaq: SLTM), the pioneer in fractional resurfacing and non-invasive skin tightening and a global market leader in aesthetic skin treatments, today, announced Health Canada approval of its new Clear + Brilliant laser aesthetic treatment. This technology is now available to physicians in Canada. In May of 2011, the company received FDA 510(K) clearance and CE Mark to market and sell Clear + Brilliant. This revolutionary...

2011-08-03 15:05:00

HAYWARD, Calif., Aug. 3, 2011 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced that it will present at the 2011 Canaccord Genuity Growth Conference at the Intercontinental Hotel in Boston on Wednesday, August 10, 2011 at 8:00 am Eastern Time. Stephen J. Fanning, Chairman, President and Chief Executive Officer, will review the company's business strategy and recent corporate events. Attendance at this conference is by...